Treatment of burn scars with the 1,550 nm nonablative fractional Erbium Laser.
BACKGROUND
Scarring is a major source of morbidity in patients with burns. Burn scars are difficult to treat and are among the worst scars seen in clinical medicine. Fractional laser resurfacing is a promising treatment option because of its unique wound healing response and depth of penetration.


OBJECTIVE
To evaluate the efficacy of nonablative fractional resurfacing as a therapeutic option for extensive cutaneous scarring in burn patients.


METHODS
Prospective, single-arm, pilot study. Ten subjects with second and third degree burn scars were treated with five nonablative fractional resurfacing treatments given at 4-week intervals. Three independent investigators evaluated subject outcomes at 3 months post-treatment (primary outcome); patients also provided subjective assessments of improvement (secondary outcome).


RESULTS
Nonablative fractional resurfacing resulted in overall improvement in 90% of subjects, as determined by independent investigators; improvements were moderate to excellent in 60%. Ninety percent of subjects had improved skin texture, 80% had improved dyschromia, and 80% had improved hypertrophy/atrophy. Patients' self-reports also revealed moderate to excellent improvements (on average) in burn scar area, and significant improvements in self-esteem at 3 months post-treatment (P = 0.03).


CONCLUSIONS
Small sample size and lack of control group.


CONCLUSIONS
Fractional resurfacing is a promising new treatment modality for burn scars. We should continue to identify novel approaches and management strategies for the spectrum of diverse burn scars so that we can better treat this patient population.
Miami Dermatology & Laser Institute, Miami, FL 33173, USA. Jwaibelmd@MiamiDermLaser.com
Jill
J
Waibel
Adam J
AJ
Wulkan
Mary
M
Lupo
Kenneth
K
Beer
R Rox
RR
Anderson
D000328:Adult; D000368:Aged; D002056:Burns / Q000150:complications*; D002921:Cicatrix / Q000209:etiology / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D053844:Lasers, Solid-State / Q000627:therapeutic use*; D028022:Low-Level Light Therapy; D008297:Male; D008875:Middle Aged; D055815:Young Adult